Value sales of paediatric consumer health are seeing healthy growth in Georgia in 2025, stimulated by the growing availability of such products in the country. Indeed, paediatric remedies are becoming more widely available across Georgian regions thanks to the growing number of pharmacies which are expanding across the country. This is further boosted by pharmacies’ efforts in enhancing their omnichannel strategies, meaning consumers can order products online and have them conveniently delivered

Paediatric consumer health in Switzerland was impacted by lower consumer demand in 2025, with consumers switching to more affordable lines. When treating children, many Swiss consumers prefer to opt for traditional and reliable home remedies or, in more severe cases, the recommendations and prescriptions from their children’s doctor. At the same time, many parents take a proactive strategy to their children’s overall health and wellbeing, providing them with the care and nutrition necessary to s

Paediatric consumer health in Ecuador is seeing further growth in 2025, despite a shrinking target audience due to declining birth rates, supported by paediatric vitamins and dietary supplements. While adult categories have struggled, paediatric supplements have proven more resilient as parents are generally willing to spend more on their children’s health, even during times of economic uncertainty.

Value sales of paediatric consumer health are maintaining positive growth in the Dominican Republic. Despite the slowdown in birth rates in this country, parents' purchasing behaviour for over-the-counter (OTC) products tends to prioritise well-positioned or paediatrician-recommended brands — which are more expensive than generic options. This behaviour differs when compared to purchasing adult products, where Dominican consumers frequently consider opting for generic or bioequivalent products d

Estonia’s paediatric consumer health market saw another increase 2025, with growth largely driven by a heavier respiratory illness season and the return to routine mixing in schools and day-care settings, which led to more symptom-driven purchases. This prompted parents to return to pharmacies for syrups, decongestants, and throat soothers for children. Fever-related purchases followed a similar trend, though with a more gradual rise. Pharmacists commonly advised keeping both paracetamol and ibu

Value sales of paediatric consumer health products in Belgium increased in 2025; however, volume sales continued to decline. This divergence highlights underlying structural and behavioural changes affecting the market.

Retail value sales of paediatric consumer health are expected to rise in current terms in Japan in 2025, mirroring trends being seen in the adult segment. Persistent levels of infectious diseases have continued to support demand in core categories such as cough, rhinitis, cold remedies, and antipyretic analgesics, which has maintained stable performance throughout the year.

Sales of paediatric consumer health have seen moderate growth in current value terms in 2025 albeit with mixed performances across the various categories. Value growth has been fuelled by the consumer preference for branded products over private label options. Growth has also been fuelled by a growing assortment of clean and non-drug formulations with consumers demanding what they perceive to be safer options for their children.

Paediatric consumer health in the United Arab Emirates is projected to see further healthy, if slower, retail current value growth over 2025. A slight uptick in birth rates and a broader selection of products are helping to maintain moderate growth rates in retail volume terms. Moreover, as parents become more proactive in dealing with children’s health issues, rising health and wellness awareness is expected to drive increased interest and engagement with specialised offerings.

Value sales of paediatric consumer health in Bulgaria increased in 2025. Parents in Bulgaria became increasingly attentive to their children’s wellbeing, fuelling demand for products addressing areas such as skin care, digestive health, immunity, and dietary supplementation. Despite the country’s ongoing demographic challenge of low birth rates, families with children continued to prioritise health spending, often opting for premium products perceived as safer or more effective. This reflects a

Value sales of paediatric consumer health in the Czech Republic increased in 2025, although the rate of expansion was moderate compared with previous years of volatility. Demand for paediatric analgesics and cough and cold remedies stabilised after earlier supply disruptions and pandemic-driven spikes in consumption. Growth was supported by more resilient categories such as paediatric digestive remedies and dietary supplements, which continued to benefit from consistent demand among parents seek

In 2025, paediatric consumer health is expected to record modest value growth in Norway. However, the category remains relatively mature and constrained, reflecting the country’s “less is more” approach to children’s healthcare. Norwegian parents tend to purchase products only when clearly needed, and typically in recommended doses. This conservative usage pattern limits sales volumes. For example, paediatric analgesics often last for several months due to the small dosages required per use. In

In 2025, value sales of paediatric health products in Colombia are recovering after a slight decrease in the previous year and are recording solid growth. With the increasing incidence of respiratory and digestive viruses - particularly marked in early 2025 - parents are following the advice of physicians and turning to OTC paediatric remedies like analgesics and digestive remedies to alleviate symptoms of conditions that generally be treated at home.

Paediatric consumer health sales rose marginally in 2025, as demand decreased for analgesics and cough and cold remedies. However, paediatric digestive remedies, nappy (diaper) rash treatments and VDS all posted an increase. Paediatric digestive remedies saw the strongest value growth driven by strong demand for diarrhoeal remedies. This category is primarily driven by Pedialyte from Abbott Laboratories Inc as well as private label products such as Life Brand Paediatric Electrolyte from Shopp

Retail value sales of paediatric consumer health products rose in Cameroon in 2025, driven by a combination of demographic, behavioural, and nutritional factors. A key driver of growth is the country’s population structure, with 41.5% of Cameroonians under the age of 15, 29.2% below 10 years, and 15.3% under five. Although the national birth rate is gradually declining, it remains relatively high at 2.6%, ensuring a continued increase in the child population and sustaining baseline demand for pa

Retail value sales of paediatric consumer health are expected to rise in current terms in South Korea. In 2025, two of the fastest-growing categories in South Korea’s healthcare market are set to be paediatric cough, cold and allergy remedies and paediatric vitamins and dietary supplements. This trend reflects a growing demand for child-friendly health solutions, especially in a country where access to prescription medication is already highly efficient. Despite the ease of obtaining prescriptio

Value sales of paediatric consumer health are rising in 2025, though seeing slight slowdown in growth compared to 2024, reflecting broader market trends. Despite this deceleration, the category is benefiting from an expanded product offering. Parents are increasingly focused on preventing illness and supporting their children’s health from an early age, driving demand for supplements tailored to different developmental stages and specific health needs. Brands like Centrum, which offer age-specif

Retail value sales of paediatric consumer health are set to rise in current terms in the UK in 2025, with a slight acceleration compared to the previous year. This uptick is primarily being driven by the strong performance of paediatric vitamins and dietary supplements, which is seeing gains in both volume and value. Notably, 2025 is the first year since the COVID-19 pandemic that paediatric vitamins and dietary supplements is expected to experience volume growth, reversing a multi-year trend of

Retail value sales of paediatric consumer health are expected to decline in current terms in Chile in 2025. The category faces a third consecutive year of contraction. Related categories, such as baby care and beauty products for infants, have also shown declines over the past three years, aligned with declining birth rates in the country. Within paediatric analgesics, decreases have been even more pronounced than in standard analgesics.

Value sales of paediatric consumer health are increasing in China in 2025, despite a declining birth rate. Parents’ heightened focus on children’s growth and development - particularly in areas such as height and brain health – is driving strong demand, and products like liquid calcium and fish oil have gained notable traction. As a relatively small and emerging segment compared with the mature adult market, paediatric consumer health shows strong growth potential and accelerated value expansion

Paediatric consumer health in Germany is projected to sustain healthy retail current value sales growth in Germany in 2025. Manufacturers and retailers are investing in marketing and communication to raise awareness of children's specific formulas, thereby building confidence and reducing concerns about the risks associated with the self-selection of medicines. The most commonly used medicines are expected to receive greater promotion in terms of child-specific extensions over 2025, with manufac

Sales of paediatric consumer health have seen solid growth in current value terms in 2025. Australian parents and caregivers are responding positively to both trusted and novel products that address the health concerns of their children. Paediatric vitamins and dietary supplements remains the largest category within paediatric consumer health, followed by nappy (diaper) rash treatments, paediatric analgesics and paediatric cough, cold and allergy remedies. Sales of paediatric consumer health pro

Value sales of paediatric consumer health increased in 2025, despite structural headwinds from a shrinking population of children in Austria. Falling birth rates continued to limit the pool of potential users, and many parents still preferred to consult a doctor first when ailments arose, which channelled some demand towards prescription options. Even so, day-to-day needs sustained purchasing of over-the-counter solutions, as households managed minor, recurring issues at home – from common colds

The market for paediatric consumer health will continue to grow current value terms in Bolivia in 2025, although this is partly the result of ongoing price increases. The scarcity of US dollars in the country has driven reliance on the parallel exchange market, raising import costs for both finished products and raw materials. Local manufacturers are also affected, as international payments carry high banking fees, adding further pressure on production costs and retail prices. However, despite t